| 2024 | 2023 | 2022 | 2021 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | 451,2 k € | |||||||||||||
| Gross margin | 175,8 k € | +14.1% | 154,0 k € | +6.0% | 145,3 k € | -21.6% | 185,4 k € | -40.5% | 311,8 k € | +8.1% | 288,4 k € | +1.1% | 285,3 k € | -9.1% | 313,8 k € | +31.6% | 238,3 k € | -12.1% | 271,2 k € | +21.1% | 224,0 k € | +34.2% | 166,9 k € | +22.5% | 136,3 k € | |
| EBITDA | 91,4 k € | +24.4% | 73,4 k € | +13.0% | 65,0 k € | -41.9% | 111,8 k € | -63.7% | 308,1 k € | +8.8% | 283,2 k € | -0.1% | 283,5 k € | -9.1% | 312,0 k € | +31.8% | 236,8 k € | -12.3% | 269,9 k € | +22.3% | 220,8 k € | +33.0% | 166,0 k € | +22.4% | 135,6 k € | |
| Operating profit | 45,1 k € | +10.3% | 40,9 k € | +19.7% | 34,1 k € | -57.4% | 80,1 k € | -61.0% | 205,4 k € | +11.8% | 183,8 k € | +1.0% | 182,1 k € | -16.1% | 217,1 k € | +27.2% | 170,7 k € | -15.9% | 202,9 k € | +26.3% | 160,6 k € | +38.9% | 115,6 k € | +35.6% | 85,3 k € | |
| Profit/loss | 71,4 k € | +8.7% | 65,7 k € | +37.7% | 47,7 k € | -21.2% | 60,6 k € | -54.4% | 132,8 k € | +134.7% | 56,6 k € | -46.3% | 105,3 k € | -0.6% | 105,9 k € | -25.0% | 141,1 k € | -24.2% | 186,2 k € | +211.4% | 59,8 k € | +410.6% | -19,3 k € | -142.1% | 45,7 k € | |
| Equity | 1,8 M € | +4.0% | 1,8 M € | +3.8% | 1,7 M € | +2.9% | 1,7 M € | +66.4% | 998,4 k € | +15.3% | 865,7 k € | +7.0% | 809,1 k € | +26.2% | 641,0 k € | +19.8% | 535,1 k € | +35.8% | 393,9 k € | +89.6% | 207,8 k € | +40.4% | 148,0 k € | -11.5% | 167,2 k € | |
| Total assets | 2,3 M € | +4.8% | 2,2 M € | +5.6% | 2,1 M € | -0.3% | 2,1 M € | +42.3% | 1,4 M € | -19.7% | 1,8 M € | +20.9% | 1,5 M € | +13.3% | 1,3 M € | -16.6% | 1,6 M € | +70.3% | 926,9 k € | +18.9% | 779,4 k € | +5.8% | 736,4 k € | -9.1% | 810,5 k € | |
| Cash | 2,1 k € | -59.5% | 5,1 k € | -29.0% | 7,2 k € | -39.9% | 12,0 k € | -80.6% | 61,8 k € | +80.9% | 34,2 k € | -68.5% | 108,4 k € | +41.7% | 76,5 k € | +10.8% | 69,1 k € | -23.8% | 90,7 k € | +13.9% | 79,6 k € | +199.6% | 26,6 k € | -60.3% | 66,9 k € | |
| Debts | 404,4 k € | +8.9% | 371,4 k € | +8.6% | 341,9 k € | -13.4% | 394,8 k € | -12.1% | 449,0 k € | -52.1% | 937,8 k € | +37.3% | 682,9 k € | +1.0% | 676,5 k € | -35.2% | 1,0 M € | +95.9% | 532,9 k € | -6.8% | 571,6 k € | -2.9% | 588,4 k € | -8.5% | 643,3 k € | |
Private company with limited liability · Aalter · incorporated on 11/08/2005
Private company with limited liability profitable and well capitalised. Cash position declining (-59.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CARDIOLOOG JAN VERCAMMEN is a Private company with limited liability incorporated in 2005. Its main activity is: Specialist medical practice activities. Its registered office is in Aalter.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette